First-in-class drug discovery

Novel Targets in the Nuclear Receptor Family

Orphagen Pharmaceuticals addresses the pharmaceutical industry’s need for new classes of drugs that have novel therapeutic mechanisms. We recognize that patients need genuinely new therapies rather than incremental improvements over existing ones.

We focus on the unexplored or “orphan” members of the nuclear receptor family, a highly successful target class.

orphagen pharmaceuticals


Orphagen Team

Our scientists and management team are committed to the best we can bring to bear in pursuit of new therapies. We are drug hunters….
Read More



Our mission is translational drug discovery and development with novel targets leading to first-in-class industry partnerships….
Read More